U.S. CDMRP – Lung Cancer Research Program | Research Funding

Thumbnail

Event details

Date 03.05.2022
Category Call for proposal
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the Lung Cancer Research Program (LCRP) Awards. Three award programs are available:
 
  • The FY22 LCRP Concept Award supports the exploration of a highly innovative new concept or untested theory that addresses an important problem relevant to lung cancer.  The Concept Award is not intended to support an incremental progression of an already established research project; instead, this award mechanism allows Principal Investigators (PIs) the opportunity to pursue serendipitous observations by supporting high-risk studies that have the potential to reveal entirely new avenues for investigation. 
     
  • The FY22 LCRP Idea Development Award mechanism promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths and suffering from lung cancer. Research applications only in the area of mesothelioma will not be accepted. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale.
     
  • The FY22 LCRP Career Development Award supports early-career, independent investigators to conduct impactful research under the mentorship of an experienced lung cancer researcher as an opportunity to obtain the funding, mentoring, and experience necessary for productive, independent careers at the forefront of lung cancer research.  This award is intended to support impactful research projects with an emphasis on discovery. Preliminary data are not required. 

All applications for LCRP funding must specifically address at least one of the Areas of Emphasis as directed by Congress and have direct relevance to military health. The FY22 LCRP Topic Areas are listed at the end of this announcement.

Funding:       Concept Award - max. $100’000
                        Idea Development Award – max. $350’000
                        Career Development Award – max. $250’000

Duration:      Concept Award – 1 year
                        Idea Development Award – 2 years
                        Career Development Award – 2 years

Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. All investigators at or above the level of postdoctoral fellow (or equivalent) are eligible for the Concept Award. All investigators at or above the level of assistant professor (or equivalent) are eligible for the Idea Development and Career Development Awards.

How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.

Pre-Application Deadline: 5:00 p.m. Eastern time (ET), May 03, 2022
Full Application Deadline: program-dependent

Grants.gov Funding Opportunity Numbers:
  • Concept Award – W81XWH-22-LCRP-CA
  • Idea Development Award –  W81XWH-22-LCRP-IDA
  • Career Development Award – W81XWH-22-LCRP-CDA

Further information
  • To see the program announcement, navigate to the search page on Grants.gov and search for the Opportunity Numbers given above
  • For questions about the eBRAP or Grants.gov platforms, contact the Research Office.

Areas of Emphasis:
  • Care Delivery and Health Disparity Option
    • Identify innovative strategies for comprehensive lung cancer care (clinical management/surveillance/symptom management/palliative care).
    • Understand factors and/or develop implementation strategies to address health disparities in lung cancer.
  • Cancer Research continuum Option
    • Identify innovative strategies for prevention of the occurrence of lung cancer.
    • Identify innovative strategies for the screening and early detection of lung cancer
    • Understand the molecular mechanisms of initiation and progression to lung cancer.
    • Understand contributions to lung cancer development other than tobacco.
    • Identify innovative strategies for the treatment of lung cancer.
    • Identify innovative strategies for the prevention of recurrence of or metastases from lung cancer.
    • Develop or optimize biomarkers to assist with therapeutic decision-making.
    • Understand mechanism of resistance to treatment (primary and secondary).

 

Practical information

  • General public
  • Free

Contact

Event broadcasted in

Share